The D.E.S.I.R study aimed to understand the development of insulin resistance syndrome by examining various metabolic and cardiovascular factors. Beginning in 1994, the study included over 2,500 male participants and over 2,600 female participants between the ages of 30 to 65 from the western region of France. The participants were followed-up ever 3-years, with the final examination taking place 9 years after baseline in 2003, including of over 3,400 remaining participants.
Study design
Cohort
Number of participants at first data collection
5,212 (participants)
Age at first data collection
30 - 65 years (participants)
Participant year of birth
1929 - 1966 (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Country
Year of first data collection
1994
Primary Institutions
Angers University Hospital Center (Centre Hospitalier Universitaire D'Angers, CHU-ANGERS)
Bichat-Claude Bernard Hospital (Hôpital Bichat-Claude-Bernard)
Centre for Epidemiology and Population Health (Centre de Recherche en Épidémiologie et Santé des Populations, CESP)
French National Centre for Scientific Research (Centre national de la recherche scientifique, CNRS)
Inter-Regional Institute for Health (Institut inter Regional pour la Santé, IRSA)
Profile paper DOI
Funders
Ardix Medical
Bayer AG
Becton Dickinson (BD)
Cardionics
Eli Lilly and Company
Ongoing?
No
Data types collected
Engagement
Keywords